Clinical Utility of Emergency Capsule Endoscopy for Diagnosing the Source and Nature of Ongoing Overt Obscure Gastrointestinal Bleeding

Table 3

Rebleeding rates stratified according to the initial treatment for ongoing overt obscure gastrointestinal bleeding.

Rebleeding rate
Group A, , CE at ≤48 h
0/12 (0%)
Endoscopic hemostasis	6 (50)
Surgery	2 (17)
Medication	1 (8)
No treatment	3 (25)
Group B, , CE at >48 h
1/53 (2%)
Endoscopic hemostasis	32 (60)
Medication	10 (20)
Interventional radiology	1 (2)
Surgery	8 (14)
No treatment	2 (4)

The patients were stratified according to the timing of CE relative to the onset of bleeding. Data are shown as frequency (percentage). Abbreviations: CE, capsule endoscopy.